Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
American Journal of Obstetrics and Gynecology 2020-Apr

Vaginal bleeding and nausea in early pregnancy as predictors of clinical pregnancy loss.

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Veza se sprema u međuspremnik
Elizabeth DeVilbiss
Ashley Naimi
Sunni Mumford
Neil Perkins
Lindsey Sjaarda
Jessica Zolton
Robert Silver
Enrique Schisterman

Ključne riječi

Sažetak

While nausea and vaginal bleeding are commonly experienced in early pregnancy, their prognostic value in predicting clinical pregnancy loss is not well understood.To understand whether timing of bleeding and nausea symptoms can be used to predict risk of pregnancy loss among women with ultrasound confirmed pregnancies.A cohort of 701 women with clinically confirmed pregnancies and 1-2 prior pregnancy losses were preconceptionally enrolled in the EAGeR trial (2006-2012). Participants completed daily symptom diaries from 2 to 8 weeks' gestation and were prospectively followed for detection of pregnancy loss. The risk of pregnancy loss was estimated for each observed bleeding and nausea pattern, and positive and negative predictive values for each pattern were calculated.Among 701 women, 38% reported any vaginal bleeding and 92% reported any nausea. Most bleeding was spotting and contained within a single episode. Vaginal bleeding occurred in 16% (16% live birth, 16% clinical loss), 15% (15% live birth, 20% clinical loss), and 21% (19% live birth, 33% clinical loss) of women within weeks 2-4, 4-6, and 6-8, respectively. Nausea was reported in 33% (34% live birth, 29% clinical loss), 66% (68% live birth, 60% clinical loss), and 87% (91% live birth, 69% clinical loss) of women within these respective epochs. Bleeding in the absence of nausea at 6-8 weeks' gestation (3.6% prevalence) had the greatest risk of clinical loss (RD = 56%, 95% CI [38, 75]), a positive predictive value of 68% [50, 86], negative predictive value of 86% [83, 88], positive likelihood ratio of 11 [2.0, 20], and negative likelihood ratio of 0.86 [0.79, 0.93]. This symptom pattern predicted clinical pregnancy loss similar to (AUC = 0.85 [0.82, 0.90]) age, BMI, blood pressure, and waist to hip ratio (AUC = 0.81 [0.78, 0.88]) measured preconceptionally.Women experiencing bleeding 6-8 weeks' gestation without accompanying nausea had an elevated risk of clinical pregnancy loss. Bleeding or nausea prior to 6 weeks' gestation were not predictive of risk of clinical loss.

Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta naukom

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti naukom
  • Prepoznavanje biljaka po slici
  • Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
  • Pročitajte naučne publikacije povezane sa vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima

Google Play badgeApp Store badge